ArticleAMB Express2026
Asiatic acid disrupts biofilm formation and shows additive effect with antibiotic against Acinetobacter baumannii.
Article in AMB Express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asiatic acid, a bioactive pentacyclic triterpenoid derived from Centella asiatica, has been widely used against infectious wounds and inflammation. Recently, this natural compound has also drawn attention to interfering with bacterial biofilms, a major phenotypic strategy that enables bacteria to survive under stress or antibiotic pressure. Acinetobacter baumannii, a nosocomial pathogen, is well known for its remarkable ability to form biofilms that promote chronic infections and contribute to conventional antibiotic resistance. The present study investigated the inhibitory effect of asiatic acid during the early stages of A. baumannii biofilm development. Despite exhibiting indirect antimicrobial activity, asiatic acid significantly reduced biofilm production in both drug-resistant clinical isolates and A. baumannii ATCC 19606 reference strain. Confocal microscopic evaluations supported the visual attenuation of biofilm structure following treatment. Molecular analyses revealed that asiatic acid downregulated the expression of critical biofilm-associated adhesion genes, csuE and bap. By suppressing these genes, this natural compound may prevent bacteria from surface attachment and interfere with the subsequent maturation of biofilms. Furthermore, asiatic acid additively contributed to antimicrobial activity of standard antibiotics against A. baumannii. These findings support the potential of asiatic acid as an adjunctive agent for the control of biofilm-associated infections caused by A. baumannii, particularly in the context of rising multidrug resistance. Continued investigation into its mechanisms and synergistic combinations may inform the development of novel anti-biofilm therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.